At the beginning of May, specialists from Bioceltix – jointly with engineers from the Czech-based Block company – conducted functional tests within the framework of a MOCK-UP study. It employed a mock-up of a modular system of the isolated technological line for the production of animal allogeneic stem cells in line with the pharmaceutical standard. The isolator technology under implementation complies with the requirements of cGMP – it is a guarantee for the optimisation of maintenance and investment expenditures as compared to conventional clean-room type facilities.
